Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
Project REMOTE (REimagining Measurements and Operations of Translational Endpoints)
NCT06776367 · View on ClinicalTrials.gov ↗
Study Summary
This trial is designed to assess immunological biomarkers measured from blood samples that can be used to reliably predict how well vaccines work against symptomatic COVID-19 as well as to evaluate the feasibility of remote, self-collected specimens when conducting a correlates analysis. For a lot of research studies, people need to go to the study doctor's office regularly. For this study, we want to see if it is okay that people do the study doctor visits virtually, fill out questionnaires electronically, and collect their own samples remotely. Participants will enroll in the study after receiving a COVID-19 vaccine in their community, and saliva and blood specimens will be collected at pre-defined time-points over a 12-month period. Additionally, participants will report weekly whether they experience symptoms of COVID-19, and if so, will be prompted to collect a nasal swab for testing. Most participants will complete all activities remotely and via electronic communications, but a small number will complete activities in person at the doctor's office to provide a comparison group. Samples from the study will be analyzed to determine whether the biomarkers can be measured, and data from the study will be used to evaluate the feasibility of doing the specimen and data collection without the participant going to the doctor's office in person.
Conditions Studied
Interventions
- OTHER Remote study participation and self-collection of specimens
- OTHER Traditional clinical trial participation with clinician-collected specimens
Study Locations (16)
California
- Apex Research Group — Fair Oaks
- Wake Research Encino — Los Angeles
- Wake Research San Diego — San Diego
Georgia
- Emory University — Atlanta
- Wake Research Atlanta — Atlanta
Alabama
- Accel Research Site Networks - Birmingham CRU / Elite — Vestavia Hills
Arizona
- Desert Clinical Research — Mesa
Florida
- Research Institute of South Florida — Miami
Kansas
- Johnson County Clinical Trials (JCCT) — Lenexa
Kentucky
- Research Integrity / WCG — Owensboro
Massachusetts
- Alcanza / hyperCORE — Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,000 participants |
| Start Date | 2024-12-20 |
| Est. Completion | 2026-07 |
Interested in This Trial?
Always speak with your doctor before enrolling in a clinical trial.
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06776367
The ClinicalTrials.gov registry entry for NCT06776367 describes a study currently listed as active not recruiting. It is categorized as an unspecified phase, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 4,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Biomedical Advanced Research and Development Authority, which has 3 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.
The record links to 1 condition, with COVID-19 appearing as the primary indexed condition, and to 2 interventions — of which Remote study participation and self-collection of specimens is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.
Geographic footprint matters for practical reasons: NCT06776367 reports 16 study locations spanning 13 distinct geographic areas — top geographies include California, Georgia, Alabama. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.
Frequently Asked Questions
What is clinical trial NCT06776367 about?
NCT06776367 is a clinical study titled "Project REMOTE (REimagining Measurements and Operations of Translational Endpoints)". This trial is designed to assess immunological biomarkers measured from blood samples that can be used to reliably predict how well vaccines work against symptomatic COVID-19 as well as to evaluate the feasibility of remote, self-collected specimens when conducting a correlates analysis. For a lot o...
What is the current status of trial NCT06776367?
This trial is currently active not recruiting. The enrollment target is 4,000 participants. The study started on 2024-12-20. Estimated completion is 2026-07.
What conditions does trial NCT06776367 study?
This clinical trial studies the following conditions: COVID-19. These conditions were identified from the trial registry and reflect the primary focus areas of the research.
What interventions are being tested in trial NCT06776367?
The interventions under investigation include: Remote study participation and self-collection of specimens (OTHER), Traditional clinical trial participation with clinician-collected specimens (OTHER). Each intervention is being evaluated for safety and efficacy as part of this clinical study.
Who is sponsoring clinical trial NCT06776367?
This trial is sponsored by Biomedical Advanced Research and Development Authority, which has 3 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.
Where is trial NCT06776367 being conducted?
This trial has 16 study locations across Alabama, Arizona, California, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How Clinical Trials Work
Understand phases 1-4, trial design, randomization, and the informed consent process.
Patient Rights in Clinical Trials
Your rights as a participant: consent, withdrawal, privacy, and who to contact.
Finding the Right Clinical Trial
A practical guide to searching trials, understanding eligibility, and evaluating options.
All Guides
Browse our complete library of clinical trial educational resources.
Read our methodology — how this data is sourced, computed, and verified.